Inside look: Garmin Health Diabetes Insight Report

April 9, 2026
Garmin Health, a globally focused division of Garmin, supports forward-thinking third-party digital health solutions with the Garmin Health Ecosystem, comprised of the Garmin product portfolio and its data integration services. In recent years, organizations and researchers have leveraged data from this ecosystem when creating new approaches to prevent, manage and study type 2 diabetes.
The newly released Garmin Health Diabetes Insight Report details several of these collaborations and shares a unique perspective from Garmin Health leadership about the growing global prevalence of type 2 diabetes.
Here is a short preview of what you can find in the report.
Introduction
Type 2 diabetes is a preventable metabolic disorder characterized by abnormal hyperglycemia. As one of the leading causes of mortality, diabetes impacts 1 in every 11 adults worldwide and is responsible for an estimated $1 trillion in health care costs. Contributing factors include the proliferation of highly processed foods, increasingly sedentary lifestyles and rapid changes in urbanization.
Evolving solutions
Digital applications have shifted care from a reactive, one-size-fits-all approach to proactive and personalized insights based upon biometric data from wearables like Garmin smartwatches1 and continuous glucose monitors (CGMs) in tandem with AI platforms. Additionally, the recent rise in peptide therapies like GLP-1 drugs has shown a significant impact. However, the cost and side effects of these medications are limiting factors, making lifestyle modifications tied to physical activity, stress and sleep enduring components of prediabetes and type 2 diabetes care.
Twin Health and other collaborators
As the creator of the first AI digital twin, U.S.-based technology company Twin Health has shown impressive results for metabolic disease reversal, prevention and optimal metabolic health. In a landmark Twin Health study conducted by the Cleveland Clinic, 71% of twin participants reduced A1C below the diabetes range, compared to just 2.4% in the control group.
Additional collaborators include:
- Diabetes2CARE (Netherlands)
- Hello Inside (Austria)
- ON LiMiT (Denmark)
- Project Embrace (United Kingdom)
- SENTI-H (Switzerland)
At the center of these innovative, AI-driven solutions is data. This is the vital intersection at which Garmin Health sits, unlocking solutions with Garmin smartwatches and data integration one collaboration at a time. As Scott Burgett, senior director of Garmin Health engineering, states in the report, “Diabetes may be one of the greatest public health issues in modern history, but we are seeing strong evidence that scalable preventive care, powered by data, can help change its trajectory.”
To learn more about how Garmin smartwatch data is being utilized by the aforementioned organizations, read the full Diabetes Insight Report.
For additional information related to Garmin Health, visit the Garmin Health solutions page. Contact us if Garmin wearable technology and the Garmin Health connected ecosystem could play a vital role in your next project.
Finally, sign up for the Garmin Health newsletter to stay up to date on the latest trends, research and innovations.
1Garmin wearable devices are consumer wellness devices and are not medical devices under the regulation of any jurisdiction, including Regulation (EU) 2017/745. They are not intended for the diagnosis, prevention, monitoring, or treatment of any disease. Any medical or clinical functionality described is provided by a third-party solution and is solely based on their interpretation of data gathered from various data sources.